About
Treatments for Neuroinflammatory Disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
128
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07058688Lead Sponsor
A Study of NTRX-07 in Participants With Alzheimer's Disease
PHASE2Recruiting
48 participants
Started: Mar 1, 2025 · Completed: Jun 30, 2026
NCT06194552Lead Sponsor
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
PHASE1Completed
32 participants
Started: Sep 6, 2022 · Completed: Jun 30, 2023
NCT04375436Lead Sponsor
Safety and Tolerability of NTRX-07 in Healthy Volunteers
PHASE1Completed
48 participants
Started: Oct 10, 2019 · Completed: Jun 30, 2020
Locations (1)
Headquarters
Gates Mills, OH, United States
Map
Loading map...